FDA has indicated that an Advisory Committee meeting is not required at this timeIn-person late-cycle review meeting ...

Shares of Precision BioSciences, Inc. (NASDAQ:DTIL) jumped 17% on Wednesday after the company announced that its gene therapy ...

Capricor Therapeutics has received an orphan drug designation for its drug aimed at potentially treating Becker Muscular Dystrophy. The biotechnology company said Tuesday that the Food and Drug ...

Capricor Therapeutics updates on Deramiocel BLA for duchenne muscular dystrophy: San Diego Thursday, June 26, 2025, 15:30 Hrs [IST] Capricor Therapeutics, a biotechnology company ...

The Scientist's content tagged with: Stargardt's Macular Dystrophy. Login. Subscribe. News; Magazines. An Interactive Experience. Current Issue. April 1, 2025. View this Issue. Archive. Quarterly ...

Access free, up-to-date clinical references regarding differential diagnosis of age-related macular degeneration. Healio's Clinical Guidance content provides valuable insights for physicians.

Capricor's DMD therapy Deramiocel is under FDA Priority Review with no major issues flagged; PDUFA date set for August 31, 2025.

Over the last two decades, the 41-year-old Chilean has spent her days bedridden, suffering from degenerative muscular dystrophy. When she finally loses her ability to speak or her lungs fail, ...